Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 18Leukemia 8Multiple Myeloma 7Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic Syndromes 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Leukemia, Biphenotypic, Acute 5Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Breast Neoplasms 4Leukemia, Myelomonocytic, Chronic 3Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Congenital Abnormalities 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Smoldering Multiple Myeloma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1

Interventions

fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Mycophenolic Acid 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1CT-P10 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Hematopoietic and Lymphoid System Neoplasm × Granulocyte Colony-Stimulating Factor × Clear all
NCT04022239 2026-01-12

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
25 enrolled

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡